Seoul, South Korea

Seung Ah Choe



 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Seung Ah Choe: Innovator in Adenosine Derivatives

Introduction

Seung Ah Choe is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of adenosine derivatives. His work focuses on innovative methods for synthesizing these compounds, which have important applications in treating inflammatory diseases.

Latest Patents

Seung Ah Choe holds 1 patent related to adenosine derivatives. The patent details methods for synthesizing these derivatives and pharmaceutical compositions that utilize them as active ingredients. These adenosine derivatives demonstrate high binding affinity and selectivity for adenosine receptors, particularly Aadenosine receptors. They act as Aadenosine receptor antagonists and exhibit anti-inflammatory activity, making them valuable for the prevention and treatment of inflammatory diseases.

Career Highlights

Throughout his career, Seung Ah Choe has worked with reputable organizations, including Fm Therapeutics Co., Ltd. and the National Institutes of Health, a component of the US Department of Health & Human Services. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Seung Ah Choe has collaborated with several professionals in his field, including Lak Shin Jeong and Hea Ok Kim. These collaborations have enriched his research and fostered innovation in the development of pharmaceutical solutions.

Conclusion

Seung Ah Choe's work in the field of adenosine derivatives showcases his commitment to advancing medical science. His innovative approaches have the potential to significantly impact the treatment of inflammatory diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…